Evidence of organ damage after cardiopulmonary bypass
- 1 September 1992
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 104 (3) , 666-673
- https://doi.org/10.1016/s0022-5223(19)34734-8
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Integrated cardiac, renal, and endocrine actions of endothelin.Journal of Clinical Investigation, 1989
- Chronic thromboxane inhibition preserves function of rejecting rat renal allograftsKidney International, 1989
- ENDOTHELIN: AN IMPORTANT FACTOR IN ACUTE RENAL FAILURE?The Lancet, 1988
- A novel potent vasoconstrictor peptide produced by vascular endothelial cellsNature, 1988
- Reactivity of human leukocyte elastase and porcine pancreatic elastase toward peptide-4-nitroanilides containing model desmosine residues. Evidence that human leukocyte elastase is selective for crosslinked regions of elastinBiochemistry, 1981
- Complement Activation during Cardiopulmonary BypassNew England Journal of Medicine, 1981
- Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass.Circulation, 1980
- Enzymatic inactivation of human alpha-1-proteinase inhibitor by neutrophil myeloperoxidaseBiochemical and Biophysical Research Communications, 1979
- Lysosomal enzyme release during cardiopulmonary bypassAnaesthesia, 1977
- MEDIATORS OF INFLAMMATION IN LEUKOCYTE LYSOSOMESThe Journal of Experimental Medicine, 1968